Cardiovascular Diseases
to Inform Care
Genetic Testing for Cardiovascular
Breakthrough Genomics offers 10 targeted Cardiovascular Focus Panels including:
- Aorta Panel (covers 51 genes)
- Arrhythmia Panel (covers 57 genes)
- Atrial Fibrillation panel (covers 19 genes)
- Brugada Syndrome Panel (covers 9 genes)
- Cardiomyopathy Panel (covers 24 genes)
- Congenital Structural Heart Diseases Panel (covers 62 genes)
- Dilated Cardiomyopathy (DCM) Panel (covers 69 genes)
- Short QT Syndrome (SQTS) Panel (covers 111 genes)
- CPTV Panel (covers 9 genes)
- ARVC Panel (covers 17 genes)
Breakthrough Genomics’ Comprehensive
Cardiovascular Test features accurate
analysis of nearly 200 genes that can impact cardiovascular health.
This test is recommended for individuals with a family history of heart conditions of who are concerned about their long-term risk to develop heart diseases.
Benefits of genetic testing for cardiovascular conditions include:
- informed recommendations for prevention and monitoring
- improved clinical management decisions and treatment options
- enhanced understanding of potential risk to family members
- cost savings by eliminating the need for unnecessary screening
procedures and checkups
© 2022 Breakthrough Genomics. All rights reserved.